Seratrodast 是一种血栓素 A2 受体 (TP) 拮抗剂，用于治疗哮喘。

Seratrodast (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.

112665-43-7

C22H26O4

354.446

AA 2414;ABT-001;塞曲司特

DMSO:200.3 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years